A critical review of pharmaceutical galactagogues

Breastfeeding Medicine

Volumn 2, Issue 4, 2007, Pages 229-242

  Anderson, Philip O ^a   Valdés, Verónica ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; KETOCONAZOLE; METOCLOPRAMIDE; OXYTOCIN; PLACEBO; PROLACTIN; SULPIRIDE;

ANXIETY; BREAST FEEDING; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DEPRESSION; DRUG FATALITY; DRUG INDUCED HEADACHE; ENTEROPATHY; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYNDROME; FATIGUE; HAIR LOSS; HEART ARREST; HEART ARRHYTHMIA; HUMAN; LACTATION; MENTAL CONCENTRATION; MILK; MILK PRODUCTION; MOTHER; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; NONHUMAN; PRIORITY JOURNAL; QT PROLONGATION; QUADRIPLEGIA; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SLEEP DISORDER; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

ADULT; BREAST FEEDING; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; LACTATION; LACTATION DISORDERS; MILK, HUMAN; OXYTOCIN; PLANT EXTRACTS; PROLACTIN; SAFETY;

EID: 37249031875     PISSN: 15568253     EISSN: None     Source Type: Journal    
DOI: 10.1089/bfm.2007.0013     Document Type: Review

References (71)

1. McNanaman JL, Neville MC. Mammary physiology and milk secretion. Adv Drug Deliv Rev 2003;55:629-641.
2. Hartmann PE, Cregan MD, Ramsay DT, et al. Physiology of lactation in preterm mothers: Initiation and maintenance. Pediatr Ann 2003;32:351-355.
3. Neville MC, Morton J. Physiology and endocrine changes underlying human lactogenesis II. J Nutr 2001;131:3005S-3008S.
4. Chen DC, Nommsen-Rivers L, Dewey KG, et al. Stress during labor and delivery and early lactation performance. Am J Clin Nutr 1998;68:335-344.
5. Daly SE, Hartmann PE. Infant demand and milk supply. Part 2: The short-term control of milk synthesis in lactating women. J Hum Lact 1995;11:27-37.
6. Daly SE, Hartmann PE. Infant demand and supply. Part 1: Infant demand and milk production in lactating women. J Hum Lact 1995;11:21-26.
7. Hartmann PE, Rattigan S, Saint L, et al. Variation in the yield and composition of human milk. Oxf Rev Reprod Biol 1985;7:118-167.
8. Leblanc H, Lachelin GC, Abu-Fadil S, et al. Effects of dopamine infusion on pituitary hormone secretion in humans. J Clin Endocrinol Metab 1976;43:668-674.
9. Andrews ZB. Neuroendocrine regulation of prolactin secretion during late pregnancy: Easing the transition into lactation. J Neuroendocrinol 2005;17:466-473.
10. Ostrom KM. A review of the hormone prolactin during lactation. Prog Food Nutr Sci 1990;14:1-44.
11. Neville MC. Anatomy and physiology of lactation. Pediatr Clin North Am 2001;48:13-34.
12. Cox DB, Owens RA, Hartmann PE. Blood and milk prolactin and the rate of milk synthesis in women. Exp Physiol 1996;81:1007-1020.
13. Howie PW, McNeilly AS, McArdle T, et al. The relationship between suckling-induced prolactin response and lactogenesis. J Clin Endocrinol Metab 1980;50:670-673.
14. Zinaman MJ, Hughes V, Queenan JT, et al. Acute prolactin and oxytocin responses and milk yield to infant suckling and artificial methods of expression in lactating women. Pediatrics 1992;89:437-440.
15. Buhimschi CS. Endocrinology of lactation. Obstet Gynecol Clin North Am 2004;31:963-979.
16. Ueda T, Yokoyama Y, Irahara M, et al. Influence of psychological stress on suckling-induced pulsatile oxytocin release. Obstet Gynecol 1994;84:259-262.
17. Gartner LM, Morton J, Lawrence RA, et al. Breastfeeding and the use of human milk. Pediatrics 2005;115:496-506.
18. Knight CH, Peaker M, Wilde CJ. Local control of mammary development and function. Rev Reprod 1998;3:104-112.
19. Wilde CJ, Addey CV, Boddy LM, et al. Autocrine regulation of milk secretion by a protein in milk. Biochem J 1995;305 (Pt 1):51-58.
20. Chantry CJ, Howard CR, Philipp BL, and the Academy of Breastfeeding Medicine Protocol Committee. ABM Clinical protocol #7: Model breastfeeding policy. Breastfeeding Med 2007;2:50-55.
21. Klaus MH. The frequency of suckling. A neglected but essential ingredient of breast-feeding. Obstet Gynecol Clin North Am 1987;14:623-633.
22. Luhman LA. The effect of intranasal oxytocin on lactation. Obstet Gynecol 1963;21:713-717.
23. Ruis H, Rolland R, Doesburg W, et al. Oxytocin enhances onset of lactation among mothers delivering prematurely. Br Med J 1981;283:340-342.
24. Fewtrell MS, Loh K, Blake A, et al. Randomised, double-blind trial of oxytocin nasal spray in mothers expressing breast milk for preterm infants. Arch Dis Child Fetal Neonat Ed 2006;91:F169-F174.
25. Cowley KC . Psychogenic and pharmacologic induction of the let-down reflex can facilitate breastfeeding by tetraplegic women: a report of 3 cases. Arch Phys Med Rehabil 2005;86:1261-1264.
26. Nemba K. Induced lactation: A study of 37 non-puerperal mothers. J Trop Pediatr 1994;40:240-242.
27. Schulster D, Gaines Das RE, et al. International standards for human prolactin: Calibration by international collaborative study. J Endocrinol 1989;121:157-166.
28. Sousa PL. Metoclopramide and breast-feeding. Br Med J 1975;1:512.
29. Guzman V, Toscano G, Canales ES, et al. Improvement of defective lactation by using oral metoclopramide. Acta Obstet Gynecol Scand 1979;58:53-55.
30. Ehrenkranz RA, Ackerman BA. Metoclopramide effect on faltering milk production by mothers of premature infants. Pediatrics 1986;78:614-620.
31. Ertl T, Sulyok E, Ezer E, et al. The influence of metoclopramide on the composition of human breast milk. Acta Paediatr Hung 1991;31:415-422.
32. Hansen WF, McAndrew S, Harris K, et al. Metoclopramide effect on breastfeeding the preterm infant: A randomized trial. Obstet Gynecol 2005;105:383-399.
33. Kauppila A, Anunti P, Kivinen S, et al. Metoclopramide and breast feeding: Efficacy and anterior pituitary responses of the mother and the child. Eur J Obstet Gynecol Reprod Biol 1985;19:19-22.
34. Kauppila A, Arvela P, Koivisto M, et al. Metoclopramide and breast feeding: Transfer into milk and the newborn. Eur J Clin Pharmacol 1983;25:819-823.
35. Kauppila A, Kivinen S, Ylikorkala O. A dose response relation between improved lactation and metoclopramide. Lancet 1981;1:1175-1177.
36. Kauppila A, Kivinen S, Ylikorkala O. Metoclopramide increases prolactin release and milk secretion in puerperium without stimulating the secretion of thyrotropin and thyroid hormones. J Clin Endocrinol Metab 1981;52:436-439.
37. Lewis PJ, Devenish C, Kahn C. Controlled trial of metoclopramide in the initiation of breast feeding. Br J Clin Pharmacol 1980;9:217-219.
38. Nappi C, Mercorio F, Nappi F, et al. [Effect of oral administration of metoclopramide on blood levels of prolactin in the puerperium]. Arch Ostet Ginecol 1981;86:75-85.
39. Tolino A, Tedeschi A, Farace R, et al. The relationship between metoclopramide and milk secretion in puerperium. Clin Exp Obstet Gynecol 1981;8:93-95.
40. Toppare MF, Laleli Y, Senses DA, et al. Metoclopramide for breast milk production. Nutr Res 1994;14:1019-1029.
41. Seema, Patwari AK, Satyanarayana L. Relactation: An effective intervention to promote exclusive breastfeeding. J Trop Pediatr 1997;43:213-216.
42. Gupta AP, Gupta PK. Metoclopramide as a lactogogue. Clin Pediatr (Phila) 1985;24:269-272.
43. de Gezelle H , Ooghe W, Thiery M, et al. Metoclopramide and breast milk. Eur J Obstet Gynecol Reprod Biol 1983;15:31-36.
44. Wright CC, Sim J. Intention-to-treat approach to data from randomized controlled trials: A sensitivity analysis. J Clin Epidemiol 2003;56:833-842.
45. Brouwers JR, Assies J, Wiersinga WM, et al. Plasma prolactin levels after acute and subchronic oral administration of domperidone and of metoclopramide: A cross-over study in healthy volunteers. Clin Endocrinol (Oxf) 1980;12:435-440.
46. Brown TE, Fernandes PA, Grant LJ, et al. Effect of parity on pituitary prolactin response to metoclopramide and domperidone: Implications for the enhancement of lactation. J Soc Gynecol Invest 2000;7:65-69.
47. Hofmeyr GJ, van Iddekinge B, Blott JA. Domperidone: secretion in breast milk and effect on puerperal prolactin levels. Br J Obstet Gynaecol 1985;92:141-144.
48. Hofmeyr GJ, van Iddekinge B. Domperidone and lactation. Lancet 1983;1:647.
49. De Leo V, Petraglia F, Sardelli S, et al. [Use of domperidone in the induction and maintenance of maternal breast feeding]. Minerva Ginecol 1986;38:311-315.
50. Petraglia F, De Leo V, Sardelli S, et al. Domperidone in defective and insufficient lactation. Eur J Obstet Gynecol Reprod Biol 1985;19:281-287.
51. da Silva OP, Knoppert DC, Angelini MM, et al. Effect of domperidone on milk production in mothers of premature newborns: A randomized, double-blind, placebo-controlled trial. CMAJ 2001;164:17-21.
52. Unnebrink, K, Windeler J. Intention-to-treat: Methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Stat Med 2001;20:3931-3946.
53. Badroui MH, Hefnawi F, Hegab M, et al. The effect of a nonhormonal drug used as a contraceptive method and lactation stimulant after delivery. Fertil Steril 1978;30:742.
54. Ylikorkala O, Kauppila A, Kivinen S, et al. Treatment of inadequate lactation with oral sulpiride and buccal oxytocin. Obstet Gynecol 1984;63:57-60.
55. Aono T, Aki T, Koike K, et al. Effect of sulpiride on poor puerperal lactation. Am J Obstet Gynecol 1982;143:927-932.
56. Aono T, Shioji T, Aki T, et al. Augmentation of puerperal lactation by oral administration of sulpiride. J Clin Endocrinol Metab 1979;48:478-482.
57. Barguno JM, del Pozo E, Cruz M, et al. Failure of maintained hyperprolactinemia to improve lactational performance in late puerperium. J Clin Endocrinol Metab 1988;66:876-879.
58. Polatti F. Sulpiride isomers and milk secretion in puerperium. Clin Exp Obstet Gynecol 1982;9:144-147.
59. Polatti F, Brambilla A, Mandelli B, Forgione A. Can pharmacologic hyperprolactinemia and breast-suction induce lactation in women with normal menstrual cycles? Clin Exp Obstet Gynecol 1984;11:123-125.
60. Ylikorkala O , Kauppila A, Kivinen S, et al. Sulpiride improves inadequate lactation. Br Med J (Clin Res Ed) 1982;285:249-251.
61. Hansen W, Hunter S, McAndrew S, et al. Metoclopramide concentration in breast milk of women delivering between 23-34 weeks gestation. Am J Obstet Gynecol 2001;185:S116.
62. Kearns GL, Butler HL, Lane JK, et al. Metoclopramide pharmacokinetics and pharmacodynamics in infants with gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1988;7:823-829.
63. Kearns GL, van den Anker JN, Reed MD, et al. Pharmacokinetics of metoclopramide in neonates. J Clin Pharmacol 1998;38:122-128.
64. Tsujikawa K, Dan Y, Nogawa K, et al. Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A. Biopharm Drug Dispos 2003;24:105-114.
65. Medicines Control Council. Interaction between ketoconazole and domperidone and the risk of QT prolongation - Important safety information. S Afr Med J 2006;96:596.
66. Anon. FDA warns against women using unapproved drug, domperidone, to increase milk production. FDA Talk Paper 2004.
67. Hampton T. FDA warns against breast milk drug. JAMA 2004;292:322.
68. Betzold C. Is domperidone safe for breastfeeding mothers? Author response. J Midwifery Womens Health 2004;49:461.
69. Straus SM, Sturkenboom MC, Bleumink GS, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J 2005;26:2007-2012.
70. Anon. Sulpiride. In: Drugdex Evaluations. Denver, CO: Micromedex, Thompson Healthcare, 2007.
71. Mauri MC, Bravin S, Bitetto A, et al. A risk-benefit assessment of sulpiride in the treatment of schizophrenia. Drug Saf 1996;14:288-298.